Following recent challenges, this Indian drugmaker is experiencing increased attention from investors. A key inquiry now revolves around whether existing market pricing offer a worthwhile opportunity. Industry observers are divided on the future, with certain pointing to the potential of revival fueled by innovations and strengthened performance… Read More